lifitegrast
Generic: lifitegrast
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
lifitegrast
Generic Name
lifitegrast
Labeler
aurobindo pharma limited
Dosage Form
FOR SOLUTION
Routes
Active Ingredients
lifitegrast 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
59651-450
Product ID
59651-450_1d4b4b61-79da-4b6f-bb19-056d111bf400
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215063
Listing Expiration
2026-12-31
Marketing Start
2023-11-07
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59651450
Hyphenated Format
59651-450
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lifitegrast (source: ndc)
Generic Name
lifitegrast (source: ndc)
Application Number
ANDA215063 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 60 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "1d4b4b61-79da-4b6f-bb19-056d111bf400", "openfda": {"nui": ["N0000192701", "N0000192700"], "unii": ["038E5L962W"], "rxcui": ["1801835"], "spl_set_id": ["1d4b4b61-79da-4b6f-bb19-056d111bf400"], "pharm_class_epc": ["Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]"], "pharm_class_moa": ["Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 POUCH in 1 CARTON (59651-450-60) / 5 AMPULE in 1 POUCH (59651-450-05) / .2 mL in 1 AMPULE", "package_ndc": "59651-450-60", "marketing_start_date": "20231107"}], "brand_name": "Lifitegrast", "product_id": "59651-450_1d4b4b61-79da-4b6f-bb19-056d111bf400", "dosage_form": "FOR SOLUTION", "pharm_class": ["Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]", "Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]"], "product_ndc": "59651-450", "generic_name": "Lifitegrast", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lifitegrast", "active_ingredients": [{"name": "LIFITEGRAST", "strength": "50 mg/mL"}], "application_number": "ANDA215063", "marketing_category": "ANDA", "marketing_start_date": "20231107", "listing_expiration_date": "20261231"}